Abiocode was founded in late 2008 in California by scientists who understand the importance of high quality reagents to biomedical research. The long-term goal of the company is to apply innovative techniques and approaches to design and produce reagents and assay systems that are of high quality and cost-effective for the biomedical research community.
The company is currently focused on high-throughput antibody production. Our goal is to produce at least two distinct antibodies that can specifically recognize two different regions of a protein, whenever possible. We believe that the availability of such antibody pairs will be important for proteomics research and for study validation.
Abiocode is also in the process of developing antibody arrays and ELISA kits for disease diagnosis and basic research. In addition, we are committed to explore and develop novel techniques that will improve the overall quality and efficiency of scientific research.